Why Are leading Swiss Pharmaceutical Companies Investing in Slovenia?
Podcast: The Swiss ConnectionPublished On: Tue Apr 23 2024
Description: Send us a textPharmaceutical giant Novartis invested billions in Slovenia, helping turn the country into a global player in generic drug production. Now, as cheap Asian competitors increasingly dominate the market, Swiss drug companies see the tiny Balkan nation playing a key role in their shift to more complex, expensive medicines.Articles and videos on Switzerland's investment in Slovenia are available on swissinfo.ch. For other science stories from Switzerland please go to www.swissinfo.ch/science.Journalist: Jessica Davis Plüss Host: Jo FahyAudio editor/video journalist: Céline Stegmüller & Michele AndinaDistribution and Marketing: Xin ZhangSWI swissinfo.ch is a public service media company based in Bern, Switzerland.
The note was deleted
The note was saved
Your message was sent